Evidence map›Paper›PMID 23045255›Full record

ReviewNature reviews. Rheumatology2012

The skeleton as an endocrine organ.

Douglas J DiGirolamo, Thomas L Clemens, Stavroula Kousteni

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Rheumatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Bone metabolism - an underappreciated player.npj metabolic health and disease · 2024
    Review
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Douglas J DiGirolamoDepartment of Orthopaedic Surgery, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA. ddigiro2@jhmi.edu
Thomas L Clemens
Stavroula Kousteni

Funding

Transcriptomic CoreP01AG032959 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gerard Karsenty · 2010 to 2026
$39.7M
The Osteoblast as a Determinant of LeukemogenesisR01AR054447 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KOUSTENI, STAVROULA · 2008 to 2017
$3.3M
Sirtuin/FOXO Signaling in the Regulation of Bone MassR01AR055931 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KOUSTENI, STAVROULA · 2008 to 2012
$2.4M
Activin receptor-based therapies for musculoskeletal diseaseR01AR062074 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI DIGIROLAMO, DOUGLAS JAMES · 2011 to 2015
$2.0M
The Growth Hormone/IGF-1 Axis in Skeletal MuscleR01AR057868 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLEMENS, THOMAS L · 2010 to 2014
$1.8M
NIAMS NIH HHS AR054447NIAMS NIH HHS AR055931NIAMS NIH HHS AR057868NIAMS NIH HHS AR062074NIA NIH HHS AG032959
6 · The paper itself

Abstract

Surprising new discoveries in the field of skeletal biology show that bone cells produce endocrine hormones that regulate phosphate and glucose homeostasis. In this Review, we examine the features of these new endocrine pathways and discuss their physiological importance in the context of our current understanding of energy metabolism and mineral homeostasis. Consideration of evolutionary and comparative biology provides clues that a key driving force for the emergence of these hormonal pathways was the development of a large, energy-expensive musculoskeletal system. Specialized bone cells also evolved and produced endocrine hormones to integrate the skeleton in global mineral and nutrient homeostasis. The recognition of bone as a true endocrine organ represents a fertile area for further research and should improve the diagnosis and treatment of metabolic diseases such as osteoporosis and diabetes mellitus.

Indexed as

Biological EvolutionSkeletonAnimalsEndocrine SystemFibroblast Growth Factor-23Fibroblast Growth FactorsGlucoseHomeostasisHormonesHumansOsteocalcinOsteocytesPhosphatesFibroblast Growth Factor-23Fibroblast Growth FactorsGlucoseHormonesOsteocalcinPhosphates

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.